2021
DOI: 10.1007/s00430-021-00701-w
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of specific in-vitro virulence gene expression and innate host response in locally invasive vs colonizer strains of Streptococcus pneumoniae

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 82 publications
0
1
0
Order By: Relevance
“…Interestingly, the problems with serotype distribution based on geographical location can impact a protein-based vaccine too. A study using PCR detection of many of the discussed pneumococcal surface proteins observed non-uniform presence of multiple proteins originally expected to be conserved ( Blumental et al., 2015 ), while another study showed downregulation of PcpA and PhtE and no changes in PLY, PspA, or PhtD when comparing serotypes 15A and 35B, two serotypes with increasing incidence rates and outside of PCV coverage ( Fuji et al., 2021 ). Partly due to these reasons, a growing effort has developed for a multi-component approach as opposed to individual proteins in vaccine design ( Table 2 ).…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, the problems with serotype distribution based on geographical location can impact a protein-based vaccine too. A study using PCR detection of many of the discussed pneumococcal surface proteins observed non-uniform presence of multiple proteins originally expected to be conserved ( Blumental et al., 2015 ), while another study showed downregulation of PcpA and PhtE and no changes in PLY, PspA, or PhtD when comparing serotypes 15A and 35B, two serotypes with increasing incidence rates and outside of PCV coverage ( Fuji et al., 2021 ). Partly due to these reasons, a growing effort has developed for a multi-component approach as opposed to individual proteins in vaccine design ( Table 2 ).…”
Section: Discussionmentioning
confidence: 99%